OpenVSafe by OpenVAERS
Search V-safe

CWC-19769-55132

3 vaccinations 3 coded responses 29 check-ins 3 free-text entries 2 call cases
Sex
Female
Age at first dose
61-65
ZIP prefix
786 / TX
Registered
2021-04-17
Relationship
Self
Race
White
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2021-04-17
    Registered in v-safe
  2. 2021-04-17
    Dose 1 — Pfizer-BioNTech
  3. 2021-04-17
    Health check-in — day 0, dose 1
    Feeling: Good · None
    Adult check-in
  4. 2021-04-19
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · Fatigue or tiredness, Nausea · Be unable to do your normal daily activities
    Adult check-in
  5. 2021-04-20
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · Site: Pain · Fatigue or tiredness
    Adult check-in
  6. 2021-04-21
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · Site: Pain · None
    Adult check-in
  7. 2021-04-22
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · Headache
    Adult check-in
  8. 2021-04-23
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · Headache
    Adult check-in
  9. 2021-04-24
    Health check-in — day 7, dose 1
    Feeling: Good · Headache
    Adult check-in
  10. 2021-05-01
    Health check-in — day 14, dose 1
    Feeling: Good
    Adult check-in
  11. 2021-05-08
    Dose 2 — Pfizer-BioNTech
  12. 2021-05-08
    Health check-in — day 0, dose 2
    Feeling: Good · Fatigue or tiredness
    Adult check-in
  13. 2021-05-09
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · Site: Pain · Fatigue or tiredness
    Adult check-in
  14. 2021-05-10
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  15. 2021-05-11
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  16. 2021-05-12
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  17. 2021-05-13
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · Headache
    Adult check-in
  18. 2021-05-14
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · Headache
    Adult check-in
  19. 2021-05-15
    Health check-in — day 7, dose 2
    Feeling: Good · None
    Adult check-in
  20. 2021-05-22
    Health check-in — day 14, dose 2
    Feeling: Good
    Adult check-in
  21. 2021-05-29
    Health check-in — day 21, dose 2
    Feeling: Good
    Adult check-in
  22. 2021-06-05
    Health check-in — day 28, dose 2
    Feeling: Good
    Adult check-in
  23. 2021-06-12
    Health check-in — day 35, dose 2
    Feeling: Good
    Adult check-in
  24. 2021-06-19
    Health check-in — day 42, dose 2
    Feeling: Good
    Adult check-in
  25. 2021-08-07
    Survey response — 3 months, dose 2
    MedDRA: Adverse reaction, Alpha-1 antitrypsin deficiency carrier, Dyspnoea, Hepatic steatosis, Office visit, Protein total decreased — Feeling: Good · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit
    Free text: Symptoms: Trouble breathing. Went to see a pulmonary doctor I have been diagnosed as a Alpha One carrier. I also have symptoms of the disease and my levels are low in the protein that my liver is supposed to be making to protect my lungs. Fatty liver · Healthcare visit (other): Doctors office/CT Scan
    MedDRA releases: 2021-09,2024-11 · check-in free text available
  26. 2021-08-07
    Report sent to call center — 3 months, dose 2
    Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional
    1 call case(s)
  27. 2021-10-07
    Dose 3 — Pfizer-BioNTech
  28. 2021-11-06
    Survey response — 6 months, dose 2
    MedDRA: Alpha-1 antitrypsin deficiency carrier — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities
    Free text: Alpha-1 Antitrypsin deficiency/carrier now taking weekly Glassia Infusion Received 3rd Covid-19 Shot on October 7th, 2021
    MedDRA releases: 2024-11 · check-in free text available
  29. 2021-11-08
    Health check-in — day 28, dose 3
    Feeling: Good
    Adult check-in
  30. 2021-11-11
    Health check-in — day 35, dose 3
    Feeling: Good
    Adult check-in
  31. 2021-11-18
    Health check-in — day 42, dose 3
    Feeling: Good
    Adult check-in
  32. 2021-11-23
    Call successful
    Participant prefers to complete VAERS report online
  33. 2022-01-08
    Health check-in — 3 months, dose 3
    Feeling: Good
    Adult check-in
  34. 2022-04-07
    Health check-in — 6 months, dose 3
    Feeling: Good
    Adult check-in
  35. 2022-10-07
    Survey response — 12 months, dose 3
    MedDRA: Alpha-1 antitrypsin deficiency, Unevaluable event — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit
    Free text: Symptoms: Diagnosed with Alpha-1 Antitrypsin Deficiency · Healthcare visit (other): Glassia infusions weekly
    MedDRA releases: 2024-11 · check-in free text available
  36. 2022-10-07
    Report sent to call center — 12 months, dose 3
    Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr
    Outpatient clinic or urgent care clinic visit · 1 call case(s)
  37. 2022-10-11
    Call successful
    Not applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill

Vaccinations

DoseDateManufacturerCo-administered
12021-04-17Pfizer-BioNTech
22021-05-08Pfizer-BioNTech
32021-10-07Pfizer-BioNTech No

Call center

2 call center cases

2 successful

See the call center timeline

Free text

Release 9 — 3 months, dose 2

2021-08-07

Symptoms: Trouble breathing. Went to see a pulmonary doctor I have been diagnosed as a Alpha One carrier. I also have symptoms of the disease and my levels are low in the protein that my liver is supposed to be making to protect my lungs. Fatty liver
Healthcare visit (other): Doctors office/CT Scan

Release 10 — 6 months, dose 2

2021-11-06

Symptoms: Alpha-1 Antitrypsin deficiency/carrier now taking weekly Glassia Infusion Received 3rd Covid-19 Shot on October 7th, 2021

Release 12 — 12 months, dose 3

2022-10-07

Symptoms: Diagnosed with Alpha-1 Antitrypsin Deficiency
Healthcare visit (other): Glassia infusions weekly

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
HCVOOffice visit ✓ · ✓
HCVOUnevaluable event · · ✓
SDAdverse reaction ✓ · ✓
SDAlpha-1 antitrypsin deficiency · · ✓
SDAlpha-1 antitrypsin deficiency carrier ✓ · ✓
SDDyspnoea ✓ · ✓
SDHepatic steatosis ✓ · ✓
SDProtein total decreased ✓ · ✓

✓ active code · ○ coded but marked inactive · blank = not in that release